Boxer Capital, LLC Macrogenics Inc Transaction History

Boxer Capital, LLC

  • $1.88 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$19.26 - $23.46 $24 Million - $29.2 Million
-1,245,000 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$19.78 - $24.67 $18.9 Million - $23.6 Million
-955,000 Reduced 43.41%
1,245,000 $25.7 Million
Q3 2017

Nov 14, 2017
BUY
$15.52 - $18.94 $34.1 Million - $41.7 Million
2,200,000
2,200,000 $40.7 Million

Others Institutions Holding MGNX

# of Institutions
132
Shares Held
55.4M
Call Options Held
215K
Put Options Held
238K
View Full List

About MACROGENICS INC

MGNX Quotes by TradingView
  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $200M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email